IL212664A0 - Use of eef1a as biomarker and a method of screening metap2 inhibitors - Google Patents
Use of eef1a as biomarker and a method of screening metap2 inhibitorsInfo
- Publication number
- IL212664A0 IL212664A0 IL212664A IL21266411A IL212664A0 IL 212664 A0 IL212664 A0 IL 212664A0 IL 212664 A IL212664 A IL 212664A IL 21266411 A IL21266411 A IL 21266411A IL 212664 A0 IL212664 A0 IL 212664A0
- Authority
- IL
- Israel
- Prior art keywords
- eef1a
- biomarker
- screening
- metap2 inhibitors
- metap2
- Prior art date
Links
- 101150001805 EEF1A gene Proteins 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
- 101150099542 tuf gene Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08019432 | 2008-11-06 | ||
| PCT/EP2009/007102 WO2010051882A1 (en) | 2008-11-06 | 2009-10-05 | Use of eef1a as biomarker and a method of screening metap2 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL212664A0 true IL212664A0 (en) | 2011-07-31 |
Family
ID=41409225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL212664A IL212664A0 (en) | 2008-11-06 | 2011-05-03 | Use of eef1a as biomarker and a method of screening metap2 inhibitors |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9151743B2 (enExample) |
| EP (1) | EP2344665B1 (enExample) |
| JP (1) | JP5347028B2 (enExample) |
| AU (1) | AU2009313167C1 (enExample) |
| CA (1) | CA2742737C (enExample) |
| ES (1) | ES2402564T3 (enExample) |
| IL (1) | IL212664A0 (enExample) |
| WO (1) | WO2010051882A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015069489A1 (en) | 2013-11-06 | 2015-05-14 | Merck Patent Gmbh | Predictive biomarker for hypoxia-activated prodrug therapy |
| KR101712982B1 (ko) * | 2015-07-31 | 2017-03-07 | 고려대학교 산학협력단 | 비알콜성지방간 조절인자 14-3-3 단백질 |
| WO2018148638A1 (en) * | 2017-02-10 | 2018-08-16 | Zafgen, Inc. | Pharmaceutical compositions of metap-2 inhibitors |
| CN108611352B (zh) * | 2018-04-20 | 2020-08-07 | 华南农业大学 | 一种拟禾本科根结线虫翻译延长因子Mg-eEF1A及其防治植物病害的应用 |
| CA3170118A1 (en) * | 2020-02-06 | 2021-08-12 | The Regents Of The University Of California | Elongation factor 1-alpha inhibitors and uses thereof |
| CN116395718B (zh) * | 2023-04-12 | 2024-12-17 | 中国科学院长春应用化学研究所 | 一种弱碱性钠盐纳米药物、其制备方法及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998056372A1 (en) * | 1997-06-09 | 1998-12-17 | Massachusetts Institute Of Technology | TYPE 2 METHIONINE AMINOPEPTIDASE (MetAP2) INHIBITORS AND USES THEROF |
| EP1337854A2 (en) * | 2000-11-14 | 2003-08-27 | Novartis AG | Method for screening anti-proliferative compounds and inhibiting tumor growth |
| US20020182701A1 (en) * | 2001-08-30 | 2002-12-05 | Saint Louis University | Dominant negative variants of methionine aminopeptidase 2 (MetAP2) and clinical uses thereof |
| US20030232383A1 (en) | 2001-11-02 | 2003-12-18 | Sylvia Daunert | Novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein |
-
2009
- 2009-10-05 WO PCT/EP2009/007102 patent/WO2010051882A1/en not_active Ceased
- 2009-10-05 AU AU2009313167A patent/AU2009313167C1/en active Active
- 2009-10-05 ES ES09778819T patent/ES2402564T3/es active Active
- 2009-10-05 JP JP2011533565A patent/JP5347028B2/ja active Active
- 2009-10-05 EP EP09778819A patent/EP2344665B1/en active Active
- 2009-10-05 US US13/127,834 patent/US9151743B2/en active Active
- 2009-10-05 CA CA2742737A patent/CA2742737C/en active Active
-
2011
- 2011-05-03 IL IL212664A patent/IL212664A0/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20110275088A1 (en) | 2011-11-10 |
| EP2344665B1 (en) | 2013-01-23 |
| AU2009313167C1 (en) | 2014-06-12 |
| AU2009313167A1 (en) | 2011-06-23 |
| US9151743B2 (en) | 2015-10-06 |
| JP5347028B2 (ja) | 2013-11-20 |
| ES2402564T3 (es) | 2013-05-06 |
| CA2742737C (en) | 2018-05-29 |
| CA2742737A1 (en) | 2010-05-14 |
| JP2012507268A (ja) | 2012-03-29 |
| WO2010051882A1 (en) | 2010-05-14 |
| EP2344665A1 (en) | 2011-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL233095A0 (en) | Biomarkers based on ratio and methods for their use | |
| EP2255263A4 (en) | REACHEMINER WITH TWO REFERENCE CLOCKS AND ITS ACTUATION METHOD | |
| EP2424857A4 (en) | DOUBLE ACTION INHIBITORS AND METHODS OF USE | |
| EP2358463A4 (en) | INDIRECT AND DIRECT METHOD FOR THE SEQUESTRATION OF POLLUTANTS | |
| PL2376507T3 (pl) | Sposób otrzymywania hydroksymetylofosfonianów | |
| IL212664A0 (en) | Use of eef1a as biomarker and a method of screening metap2 inhibitors | |
| GB0810990D0 (en) | Device and method of making solid beads | |
| ZA201107666B (en) | Multi-ram drill rig and method of operation | |
| GB0701599D0 (en) | Method of detection | |
| IL213064A0 (en) | Method of determining a characteristic | |
| ZA201105571B (en) | Method of blasting | |
| GB0817384D0 (en) | Method of providing location data | |
| ZA201107487B (en) | Substituted 4-amino-5-benzoyl-2(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors | |
| GB0802009D0 (en) | Biomarkers of aminopeptidase inhibition | |
| PL2312271T3 (pl) | Sposób określania wielkości dotyczących stanu morza | |
| PL2411376T3 (pl) | Inhibitory nf-kb | |
| EP2431738A4 (en) | SCREENING PROCESS FOR OSTEOPONTIN INHIBITOR AND INHIBITOR MANUFACTURED THEREWITH | |
| GB0710636D0 (en) | Method of indentifiying biomarkers | |
| GB0813688D0 (en) | Method of determination | |
| GB0713774D0 (en) | Method of determination | |
| PL385436A1 (pl) | Sposób otrzymywania 5-hydroksykreatyniny i N-metyloguanidyny | |
| GB0710768D0 (en) | Method of identifying biomarkers | |
| PL385483A1 (pl) | Sposób wyznaczania właściwości dysypatywno-sprężystych materiałów | |
| GB0809975D0 (en) | A multi-optic rule and method of use | |
| GB0613968D0 (en) | Method of determination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |